Prof Dr Idress Khan

FACULTY



Dr. Muhammad Idrees

Meritorious Professor (BPS-22)

HEC Distinguished National Professors - Liftime Title

* Fellow, Pakistan Academy of Sciences
* Fellow, Royal College of Pathologists, England
* Former Vice-Chancellor, University of Peshawar
* Former Vice-Chancellor, Hazara University
* Former Director, CAMB, University of the Punjab


Virology Lab
email: idreeskhan@cemb.edu.pk

Prof. Idrees obtained his Ph. D. in Molecular Biology/Virology and then worked for his post-doctoral research at Division of Viral Hepatitis, Coordinating Centre for Infectious Diseases, Centers for Disease Control and Prevention (CDC), Atlanta USA. As recognition of tremendous contribution in the field of Molecular Biology/Virology, The Royal College of Pathologists London-UK awarded him with Fellowship of the College in 2015 upon the recommendation of Exam Committee and College Council. Dr. Idrees currently holds a senior faculty position of Meritorious Professor (BPS-22) at the Centre of Excellence in Molecular Biology (CEMB). Prof. Idrees has been affiliated with CEMB and the Centre for Applied Molecular Biology (CAMB), University of the Punjab, for over 25 years. During this time, he has held positions ranging from Research Officer to Professor and Director. He also served as Vice Chancellor of Hazara University from July 28, 2016, to July 28, 2019, and most recently led the University of Peshawar as its 24th Vice Chancellor from December 12, 2020, to December 11, 2023.

Dr. Idrees has over 25 years of extensive experience in academics, research, administration, and financial management. Early in his career, Prof. Idrees established a cutting-edge PCR-based diagnostic laboratory at CAMB, providing accessible and accurate diagnostics for infectious and genetic diseases. This initiative not only generated over Rs. 500 million in revenue but also spearheaded the development of indigenous molecular diagnostic kits for diseases such as HBV, HCV, M. tuberculosis, dengue, and SARS-CoV-2. His team performed more than 40,000 free PCR tests for hepatitis patients under the PM’s Hepatitis Prevention Program, delivering services valued at over Rs. 113 million. Additionally, he founded a state-of-the-art Molecular Virology Division at CEMB, significantly advancing scientific and clinical research through modern molecular techniques. He has been a member of various university Senates, Syndicates, Academic Councils, and other academic bodies, serving in leadership roles such as Chairman and Convener. His contributions extend to the development of molecular diagnostics facilities, research programs, and modern academic disciplines, making significant impacts in virology and public health. His scientific interests lie in basic and applied research using advanced molecular techniques. He established a state-of-the-art Molecular Virology Division at a public university and has authored more than 270 research papers in national and international journals, with an overall impact factor exceeding 1070 and citations surpassing 8,000. He also serves as an editor for several international scientific journals and has successfully mobilized funding worth over Rs. 3 billion from national and international agencies.

Prof. Idrees has been instrumental in restructuring organizations and launching academic programs. In 2015, he played a pivotal role in developing internationally acclaimed teaching and research initiatives in Applied Molecular Biology and Forensic Sciences. At Hazara University, he spearheaded the approval and launch of ten market-oriented academic disciplines. His contributions have been recognized with numerous accolades, including the TWAS “Best Young Scientist of the Year Award in Biology” (2009), the PAS Gold Medal in Emerging Technologies (2017), and the PCST Research Productivity Awards (2011–2017). Most recently, he received the Academic Excellence Awards from the APSUP in 2022 and 2023 for his exceptional contributions to academia and higher education in Pakistan. He has contributed to the development of guidelines for managing viral diseases and has played key roles in national quality assurance and accreditation processes. Dr. Idrees’s international engagements include collaboration with leading researchers and institutions, participation in global scientific events, and extensive training in leadership and governance. His achievements in institutional financial management and developmental projects have set benchmarks in the higher education sector. Through his tireless efforts, he continues to advance the fields of molecular biology and virology while contributing to the broader landscape of higher education and research in Pakistan.

SELECTED PUBLICATIONS (LAST FIVE YEARS ONLY; 2020-2026)

SELECTED PUBLICATIONS IN YEAR 2026

  1. Jorge R Ledesma*, Meixin Zhang*, Mei Fong Liew*, Muhammad Idrees et al. (Collaborators). Global, regional, and national burden of tuberculosis and multidrug-resistant tuberculosis by HIV status, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023. The Lancet Infectious Diseases. 01 July 2026; In Press. https://doi.org/10.1016/S1473-3099(26)00295-1. IF 29.4.
  2. Arif, MA; Mubashir, F; Raffay, A; Talha, M; Zohaib, M; Khan, AR; Naseer, MU; Khan, MH; Idrees, M. Recent Advances in CRISPR-Cas Systems for Dengue Virus Detection. Critical Reviews in Eukaryotic Gene Expression. March 2026; 36(1): 19-35. DOI: 1615/CritRevEukaryotGeneExpr.2025062420 . IF 1.62.
  3. Thai H, Almas I,Xia G, Lin Y,Sims S,Longmire A, Arthur L, Idrees M, Afzal S, Khudyakov Y. A high prevalence of hepatitis B virus strains sharing a single S gene variant in Pakistan. Infection, Genetics and Evolution. 25 July 2026; Volume 141, 105949. IF 2.81
  4. Taufiq, I.; Naveed, H.; Amin, I.; Shahid, M.; Idrees, M.; Afzal, S. 2026. Genetic Profiling of Interleukin Variants and their Correlation with Hepatitis C Viral Response to Different Therapeutic Strategies Administered in Pakistani Patients. Journal of Interferon & Cytokine Research, June 2026. IF 2.0.
  5. Aftab, A.; Afzal, S.; Idrees, M.; Ahmad, A.; Naz, T.; Sharma, V.; Ali, L. 2026. HRCT: A Tool to Curtail the Spread Rate of SARS-CoV-2 for Early and Authentic Triaging of COVID-19 Patients. EC Microbiology, May 2026; 22(5): 1-7. IF 1.782

SELECTED PUBLICATIONS IN YEAR 2025

  1. Saleem K, Akbar HR, Jilkova ZM, Afzal S, Idrees M. Polymorphisms in IL-10- and IL-22-Binding Protein Genes as Genetic Predictors of the Direct-Acting Antivirals Treatment Response in Patients with Chronic Hepatitis C Virus. Journal of Interferon & Cytokine Research. 19 March, 2025; https://doi.org/10.1089/jir.2025.0005. IF 2.0
  2. Kashif M, Minhas S, Jahan S, Idrees M. Exploring HPV-linked head and neck cancer in Southern Punjab, Pakistan: Insights from HPV-16 phylogenetic analysis. Journal of Taibah University Medical Sciences; 25 March 2025; 20 (2): 242-250. ISSN: 1658-3612 (Electronic). 1658-3612 (Linking). https://doi.org/10.1016/j.jtumed.2025.03.001. IF 1.5
  3. Aftab A, Naveed H, Idrees H, Ali L, Idrees M. The emerging role of epigenetics (DNA methylation) in hepatitis C virus-induced hepatocellular carcinoma. Gastrointestinal Tumors 7 May 2025; 12: e009 https://doi.org/10.48130/git-0025-0007. IF 0.8
  4. Shahid M, Amin I, Nawaz R, Afzal S, Idrees M. LncRNA HULC and LncRNA HOTAIR expression profile are strong predictors of direct antiviral agents therapy response in chronic Hepatitis C Virus-infected patients. Egyptian Liver Journal. 01 Aug 2025; 15(40): ISSN: 2090-6226. https://doi.org/10.1186/s43066-025-00444-w. 0.73. IF 0.73
  5. Hassan A, Mahmood MS, Idrees M, Afzal S. Development of a Multiple Epitopes-Based Dengue Vaccine: An Immunoinformatics Approach and Insights From Pakistani Population Genetics. Microbiology and Immunology, 08 Oct 2025; 69(10): Online ISSN:1348-0421; Print ISSN:0385-5600. https://doi.org/10.1111/1348-0421.70015 IF 1.8.
  6. Sahibzada KI, Abid R, Nisar H, Rahman RAA, Idrees M, Wei DQ, Hu, Y. Sadaf S. HCV genotyping and rational computational designing of an immunogenic multiepitope vaccine against genotype 3a. Journal of Computer-Aided Molecular Design, 10 Nov 2025; 39: 121. https://link.springer.com/article/10.1007/s10822-025-00698-x. IF 3.1.
  7. Nawaz R, Nawaz A, Arif MA, Rehman Z, Shah R, Shafi F, Javaid M, Idrees H, Shahid M, Amin I, Afzal S, Idrees M. Characterization of the Hepatitis C Virus: Comprehensive Molecular and Epidemiological Insights from Pakistan. BMC Infectious Diseases. Dec 2025; Accepted for publication. IF 3.0.

SELECTED PUBLICATIONS IN YEAR 2024

  1. Minhas S, Kashif M, Nisar H, Idrees M. Whole-genome analysis and evolutionary characterization of cervical and oral human papillomavirus 16. Experimental Biology and Medicine Jan 2024; X: 1–9. DOI: 10.1177/15353702231211861. IF 4.033
  2. Ullah S, Naveed M, Ali A, Bibi S, Idrees W, Idrees M. Assessment of ubiquitin specific Peptidase-18 gene in peripheral blood of chronic hepatitis C patients treated with direct-acting antiviral drugs. 30 JAN 2024; Heliyon 10 (2): e24581. IF 3.776
  3. Minhas S, Kashif M, Nisar H, Idrees M. Exploring the Concordance between High-Risk Human Papillomavirus Infections in Cervical and Oral Sites among Females: A Cross-Sectional Study in Punjab, Pakistan. 2024; JCO Global Oncology. April 25 2024; 10:e2300408. doi: 10.1200/GO.23.00408. IF 4.50.
  4. Amin I, Rafique S, Ali A, Idrees M. et al. Improving Access to Anti-HDV Testing: Development and Validation of an Affordable In-House ELISA Assay. ACS Omega April 5, 2024, 9, 15, 17137–17142. IF 4.132
  5. Zahra N, Rafique S, Naveed Z, Idrees M. Regulatory pathways and therapeutic potential of PDE4 in liver pathophysiology. Life Science, 21 March 2024; 122565. IF 6.1.
  6. Mahmud T, Idrees M, Rafique S. The Factors Associated With Mutant Epidermal Growth Factor Receptor Positivity in Patients With Lung Cancer: A Study From a Tertiary Care Center in Pakistan.18 Sep 2024; Cureus 16(9): e69631. DOI 10.7759/cureus.69631. IF 1.2
  7. Nawaz R, Ahmad M, Raza MS, Rashad M, Nawaz A, Tabassum K, Hassan JU, Ahad A, Idrees M. Coincidence of HCV and chronic kidney disease-a systematic review and meta-analysis. BMC Public Health. 2024 Oct 16;24(1):2842. doi: 10.1186/s12889-024-20331-0. PMID: 39415151; PMCID: PMC11481586. IF 3.9.
  8. Nawaz R, Husnain A, Arif mA, Idrees M. Computational prediction of a phage cocktail active against multidrug-resistant bacteria. 13 Nov 2024; F1000Research 2024, 13:1292. IF 1.51.
  9. Almas I, Tariq S, Amin I, Shahid M, Idrees M, Afzal S. Molecular epidemiology and genetic characterization of hepatitis B virus in two major provinces of Pakistan. Arch Virol. 2024 Nov 5;169(11):239. doi: 10.1007/s00705-024-06163-8. IF 2.70.

SELECTED PUBLICATIONS IN YEAR 2023

  1. Wahid B, Kumari B, Saifullah KM, Idrees M. The History and Current Killings of Polio Vaccinators in Pakistan: A Need for Targeted Surveillance Strategy. Asia Pac J Public Health. March 2023; 35 (2-3):183-188. IF 2.287
  2. Rabia N, et al. Idrees M. Structural Analysis and Epitope Prediction of S2 Domain of SARS-CoV-2, Conservation Analysis amongst Major Variants. Viral Immunology; 2023 Mar;36(2):110-121. doi: 10.1089/vim.2022.0101. Epub 2023 Jan 10. IF 2.257
  3. Shah SZ, Jabbar B, Mirza MU, Waqas M, Idrees M. et al. An Immunoinformatics Approach to Design a Potent Multi-Epitope Vaccine against Asia-1 Genotype of Crimean–Congo Haemorrhagic Fever Virus Using the Structural Glycoproteins as a Target. Vaccines 2023, 11(1), 61; https://doi.org/10.3390/vaccines11010061. IF 4.961
  4. Khan R, Ali A, Bibi S, Rafique S, Idrees M, Halim SA, Waqas M, Bahadar H, Uddin J, Khan A, Al-Harrasi A. Expression Profiling of the Tripartite Motif Family Genes in Chronic Hepatitis C Patients. ACS Omega 07 JUL 2023; 8: 25370-25377. IF 4.132
  5. Ali A, Waqar M, Akram A, Rafique S, Rehman G, Idrees M, Halim SA, Waqas M, Uddin J, Gojayev A, Khan A, Al-Harrasi A. Seroprevalence of SARS-CoV-2: Insights into the epidemiology of the pandemic. J. Infect. Public Health. August 2023;16:1256-61. IF 7.537.
  6. Chudhary HF, Ali A, Bibi S, Waqas M, Rafique S, Idrees M, Halim SA, Abdellattif MH, Khan A, Al-Harrasi A. Transcriptional Analysis of TP53 Gene in Chronic Hepatitis C Patients Treated with Sofosbuvir, Daclatasvir, Pegylated Interferon, and Ribavirin. ACS Omega April 11 2023; 8 (16):14784-14791. IF 4.132
  7. Noor F, Nawaz R, Ahad A, Ajmal A, Abrar S, Shahid M, Sarwar A, Naz A, Mehmood U, Idrees M. Structural Analysis and Epitope Prediction of S2 Domain of SARS-CoV-2, Conservation Analysis Among Major Variants. Viral Immunol 13 Mar 2023;36(2):110-21. IF 2.257.
  8. Ahmed S, Vajeeha A, Idrees M, Hussain A, Munir R, Zaidi G, Zahid K, Ahmed R, Fatima Z, Rafique S, Achakzai NM. Genotypic distribution of human papillomavirus and phylogenetic analysis of E6 and E7 gene of HR-HPV variants isolated from Pakistani population. Medicine (Baltimore) 13 Jan 2023;102(2): e32651. doi: 10.1097/MD.0000000000032651. IF 1.6.
  9. Riaz HA, Nishwa DE, Fatima A, Wahid B, Ali A, Kumari B, Idrees M. Risk of adverse outcomes following treatment with direct acting antiviral drugs in HCV infected patients with liver cirrhosis. Heliyon 13 May 2023; 9(5):e16169. IF 4.0
  10. Nawaz R, Arif MA, Idrees M, An ncRNA transcriptomics-based approach to design siRNA molecules against SARS-CoV-2 double membrane vesicle formation and accessory genes. BMC Infectious Diseases. 12 Dec 2023; 12;23(1):872. doi: 10.1186/s12879-023-08870-0. ISSN: 1471-2334. IF 3.7.
  11. Bibi S, Nisar S, Rafique S, Waqas M, Idrees M. Harnessing Nature’s Gifts: Salix nigra and Its Potential for Combating Hepatitis C Virus (HCV). ACS Omega 30 Oct 2023; 8: 42987−42999. IF 4.132.

SELECTED PUBLICATIONS IN YEAR 2022

  1. Manzoor S, Idrees M, Khalid M. P2X4 receptors mediate induction of antioxidants, fibrogenic cytokines and ECM transcripts; in presence of replicating HCV in invitro setting:  an insight into role of P2X4 in fibrosis. PLOSONE, 2022; ISSN: 1932-6203. IF 3.752.
  2. Minhas S, Kashif M, Rehman Z, Idrees M, Ansari F. Molecular characterization and risk factors of oral high-risk human papillomavirus among females in Punjab, Pakistan. Journal of Medical Virology 2022 May 29. doi: 10.1002/jmv.27893. IF 20.693.
  3. Mir I, Aamir S, Shah SRH, Shahid M, Amin I, Afzal S, Nawaz A; Khan MU, Idrees M. Immune-related therapeutics: an update on antiviral drugs and vaccines to tackle the COVID-19 pandemic. Osong Public Health and Research Perspectives. 2022; 13(2): 84-100. DOI: 24171/j.phrp.2022.0024. IF 1.227.
  4. Sahibzada KI, Ganova-Raeva L, Dimitrova Z, Ramachandran S, Lin Y, Longmire G, Arthur L, Xia GL, Khudyakov Y,  Idrees M, Sadaf  Hepatitis C virus transmission cluster among injection drug users in Pakistan. PLoS One. 2022 Jul 15;17(7):e0270910.  doi: 10.1371/journal.pone.0270910. IF 3.752.
  5. Butt F, Shahid M, Hassan M, Idrees M. A review on hepatitis C virus: role of viral and host-cellular factors in replication and existing therapeutic strategies. December 2022; Egyptian Liver Journal 12(1): DOI:1186/s43066-022-00232-w. IF 0.93.
  6. Munir R, Rafique S, Ali A, Amin I, Ahmed S, Vajeeha A, Shahid M, Samiullah TR, Idrees M, Tao YJ, Khan MU. Molecular characterization of recombinant premembrane protein of dengue virus serotype‐2 for development of diagnostic assay. J Basic Microbiol2022; 63:489-498. IF 3.1
  7. Hanif, A, Shahid, AA, Khan, IU, Idrees, M, Ismail, M. HLA Polymorphism in Punjabi Population of Pakistan. International Journal of Human Genetics. 21 Jul 2022; 22(1): 26-35. 10.31901/24566330.2022/22.01.797. IF 0.1

SELECTED PUBLICATIONS IN YEAR 2021

  1. Ashraf MU, Salman HM, Khalid MF, Khan MHF, Anwar S, Afzal S, Idrees M, Chaudhray SU, CRISPR-Cas13a mediated targeting of hepatitis C virus internal-ribosomal entry site (IRES) as an effective antiviral strategy. Biomedical and Pharmacotherapy. 2021 Jan 19; 136: 111239. doi: 10.1016/j.biopha.2021.111239. IF 7.419.
  2. Aftab A, Afzal S, Idrees M, Shahid AA, p53 and rb promoter methylation in hepatitis C virus-related chronic hepatitis and hepatocellular carcinoma. Future Virology, 2021; 11 Jan 2021; 16(1): https://doi.org/10.2217/fvl-2020-0154. IF 3.11
  3. Hassan M, Zalkifal M, Wahab A, Afzal S, Rafique S, Shahid M, Khan M, Ahmad N, Idrees M, Shahid AA. Novel Coronavirus: A Review from Origin to Current Status of Therapeutic Strategies. Critical ReviewsTM in Eukaryotic Gene Expression, 2021; 31(3):21–34. IF 2.333
  4. Minhas S, Kashif M, Rehman Z, Pasha MB, Idrees M, Ansari F. Distribution of High-risk Human Papillomavirus Genotypes in Cervical Secretions in Punjab. Journal of the College of Physician & Surgeon Pakistan (JCPSP), 2021; 31(07): 786-791. ISSN: 1022-386X. IF 1.022
  5. Rao JR, Rafique S, Ali A, Rehman G, Ilyas M, Idrees M. Next-generation sequencing studies on the E1-HVR1 region of hepatitis C virus (HCV) from non-high-risk HCV patients living in Punjab and Khyber Pakhtunkhwa, Pakistan. Archives of Virology, Aug 27, 2021; 166(11):3049-3059.. doi: 10.1007/s00705-021-05203-x. IF 2.70
  6. Wahid B, Rani N,Idrees M. Cytokine storm syndrome in SARS-CoV-2: a review. Z Naturforsch C J Biosci. 2021 Aug 24; 77(1-2):65-69. doi: 10.1515/znc-2021-0062. IF 1.683
  7. Aftab A, Afzal S, Qamar Z, Idrees M. Early detection of MDR Mycobacterium tuberculosis mutations in Pakistan. August 2021. Scientific Reports11(1): 16736 DOI:1038/s41598-021-96116-x. IF 5.228.
  8. Waqar M, Wahid B, Ali M,Idrees M. Seroprevalence of SARS-CoV-2 in Pakistan: an update on epidemiological trends. Z Naturforsch C J Biosci. 2021 Jun 22; 76(9-10): 425-429. doi: 10.1515/znc-2020-0291. IF 1.683.
  9. Hassan M, Hassan A, Farooq M, Afzal S, Shahid M, Idrees M, Shahid AA. Dengue vaccines; ongoing challenges and current status in advancement of different vaccine candidates. January 2021; Crit Rev Eukaryot Gene Expr. 2021;31(5):7-19. DOI:1615/ CritRevEukaryotGeneExpr.2021038839. IF 2.333.
  10. Sabri S, Idrees M, Rafique S, Ali A, Khan MS. Identification and expression analysis of antigenic sites of hepatitis C virus genotype 3a NS3 and NS5A genes of local isolate. Egypt Liver Journal.2021; 11: 17 (2021). https://doi.org/10.1186/s43066-021-00086-8. IF 0.93
  11. Khalid F, Ali A, Fawad N, Rafique S, Idrees M. MMTV-LIKE virus and c-myc over-expression are associated with invasive breast cancer. Mar 2021; Infection Genetics and Evolution Mar 2021; 91(4):104827. IF 4.4.
  12. Wahid B, Amir A, Ameen A, Idrees M. Current status of therapeutic approaches and vaccines for SARS-CoV-2. Future Microbiol DOI: 10.2217/fmb-2020-0147. IF 3.1.
  13. Bukhari MMM, Mir I, Idrees M, Afzal S, Shahid M. Role of MicroRNAs in Establishing Latency of Human Immunodeficiency Virus. Crit Rev Eukaryot Gene Expr2021; 30:337-348. IF 2.333.
  14. Rafique S, Zahid S, Ali A, Tariq M, Saeed M, Iqbal Sahibzada K, Ali Shahid A, Idrees M. Genome-wide methylation profiling of HCV pathogenesis to develop diabetes and diabetic complications. J Viral Hepat2021; 28:245-259. 179.
  15. Rao JR, Rafique S, Ali A, Idrees M. Next-generation sequencing studies on the E1-HVR1 region of hepatitis C virus (HCV) from non-high-risk HCV patients living in Punjab and Khyber Pakhtunkhwa, Pakistan. Archives of Virology; 2021 Nov; 166(11): 3049-3059. IF 2.70.

 

SELECTED PUBLICATIONS IN YEAR 2020

  1. Naveed M, Ali M, Sheikh N, Rafique S, Idrees M. Expression of TRIM22 mRNA in chronic hepatitis C patients treated with direct-acting antiviral drugs. APMIS Journal of Pathology, Microbiology and Immunology, 2020 Apr;128(4):326-334. doi: 10.1111/apm.13024. IF 3.205
  2. HassanA, Saeed A, AfzalS, Shahid M, Amin I, Idrees M. Applications and hazards associated with carbon nanotubes in biomedical sciences. Inorganic and Nano-metal Chemistry. 17 Feb 2020; 50(9): 741-752. https://doi.org/10.1080/24701556.2020.1724151. IF 3.1.
  3. Shahid M, Idrees M, Amin I, Rasool A, Afzal S. Blood based gene expression profile of oxidative stress and antioxidant genes for identifying surrogate markers of liver tissue injury in chronic Hepatitis C patients. Archives of Virology 2020; 165:809–822.  IF 2.70
  4. Afzal M, Ali, A. Sheikh N, Rafique S, Idrees M, Peripheral Expression of CXCL10 Gene in Chronic Hepatitis C Patients treated with Sofosbuvir, Daclatasvir and Ribavirin. 2020; Journal of Interferon and Cytokine Research.2020; 40(6): IF 3.657.
  5. Shaheen M, Afzal S, Khubaib B, Amin I, Shahid M, Idrees M, Association of IL28B polymorphism with clearance of Hepatitis C Virus: A mini review. Critical Reviews in Eukaryotic Gene Expression. 2020; 30(3): 223-229. IF 2.333
  6. Afzal S, Almas I, Imtiaz H, Shaheen MA, Daud M, Saghir A, Amin I, Shahid M, Idrees M. Drug resistance in Hepatitis C Virus:  Future prospects and strategies to combat it. Critical Reviews in Eukaryotic Gene Expression. 2020; 30(4):323-336. IF 2.333.
  7. Ali S, Afzal S, Yousaf MZ, Amin I, Shahid M, Idrees M. Paradoxical Role of Dengue Virus Envelope Protein Domain III Antibodies in Dengue Virus Infection. Critical Reviews in Eukaryotic Gene Expression. 2020; 30(3):199-206. IF 2.333
  8. Zahid K, Sana Shakoor S, Sajid HA, Afzal S, Ali L, Amin I, Shahid M, Idrees M.. Advancements in developing an effective and preventive Dengue Vaccine. Future Virology 24 March 2020; 15(2): https://doi.org/10.2217/fvl-2019-0080. IF 3.1.
  9. Wahid B, Shami K, Idrees M. Comparing the risk of hypothyroidism in HCV patients treated with different DAA drugs combination (sofosbuvir + interferon + ribavirin and sofosbuvir + daclatasvir + ribavirin). Journal of Medical Virology, 2020; 25931. DOI: 10.1002/jmv.25931. IF 20.693.
  10. Rafiq S, Zahid S, Ali A, Sheikh N, Rafique S, Idrees M (2020). Genome wide methylation profiling of HCV pathogenesis to develop diabetes and diabetic complications. Journal of Viral Hepatitis. Oct 15, 2020; 28(8): Online ISSN:1365-2893. IF 4.179.
  11. Bukhari MMM, Shahid M, Mir I, Idrees M, Afzal S. Role of Micro RNAs in Establishment of Human Immunodeficiency Virus Latency. January 2020; Critical Reviews in Eukaryotic Gene Expression30(4): DOI:1615/CritRevEukaryotGeneExpr.2020034571. IF 2.333.
Resume
Research Gate
Google Scholar